Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call Transcript

November 08, 2025 04:56:20 pm

Source: SeekingAlpha

2025-11-08 16:56:20 ET

Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST...

For further details see:

Ligand Pharms Glucagon

0.96% G/L:

$0.0021 Last:

100 Volume:

$0.00208 Open:

Market Cap $3,679,103,920

Float 18,304,000

Insiders Ownership N/A

Institutions 151

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Jupiter